-
Something wrong with this record ?
Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases
T. Vymazal, M. Krecmerova, V. Bicek, R. Lischke,
Language English Country New Zealand
Document type Journal Article
NLK
Directory of Open Access Journals
from 2009
Free Medical Journals
from 2005 to 4 months ago
PubMed Central
from 2005
Europe PubMed Central
from 2005
ProQuest Central
from 2005-01-01
Open Access Digital Library
from 2005-01-01
Open Access Digital Library
from 2009-01-01
Taylor & Francis Open Access
from 2005-12-01
Nursing & Allied Health Database (ProQuest)
from 2005-01-01
Health & Medicine (ProQuest)
from 2005-01-01
Health Management Database (ProQuest)
from 2005-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2005
PubMed
26508869
DOI
10.2147/tcrm.s93009
Knihovny.cz E-resources
- Publication type
- Journal Article MeSH
PURPOSE: Myasthenia gravis (MG) is an autoimmune disease interfering with neuromuscular transmission. Patients are at risk of postoperative residual curarization (PORC) if nondepolarizing muscle relaxants are used. Clinically inapparent insufficient muscle strength may result in hypoventilation and postoperative bronchopneumonia. We describe a cohort of 117 cases in which sugammadex was used in MG patients undergoing surgery with muscle relaxation with rocuronium. METHODS AND PATIENTS: We anesthetized 117 patients with MG using rocuronium and sugammadex as neuromuscular blockade reversal agent. One hundred five patients underwent surgical thymectomy and 12 underwent cholecystectomy (five laparotomic and seven laparoscopic). We measured time from sugammadex administration to recovery and to extubation, using the TOF-Watch(®) (series of four consecutive electrical impulses [the train-of-four] >0.9). We tracked peripheral capillary oxygen saturation (SpO2) <95%, elevation of partial pressure of carbon dioxide (pCO2) >10% above baseline, number of reintubations within the first 48 hours, and number of pneumonias within 120 hours, postoperatively. Results were processed as average, minimum, and maximum values. RESULTS: The period needed to reach train-of-four of 0.9 following sugammadex administration was on average 117 seconds (minimum of 105 seconds/maximum of 127 seconds) and differed within deviation <10%. The time to extubation following sugammadex administration was on average 276 seconds (minimum of 251 seconds/maximum of 305 seconds) and differed minimally among patients as well. We observed no SpO2 <95%, no pCO2 elevation >10% above a baseline, no emergent reintubation within the first 48 hours, and no pneumonia diagnosed on clinical basis within 120 hours, postoperatively in all 117 patients. CONCLUSION: In this cohort of MG patients undergoing surgery using rocuronium and sugammadex, we did not observe any signs of postoperative residual curarization and respiratory depression. The neuromuscular blockade recovery was reliable, predictable, and rapid.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16000906
- 003
- CZ-PrNML
- 005
- 20160127122225.0
- 007
- ta
- 008
- 160108s2015 nz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.2147/TCRM.S93009 $2 doi
- 035 __
- $a (PubMed)26508869
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a nz
- 100 1_
- $a Vymazal, Tomas $u Department of Anaesthesiology and ICM, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 245 10
- $a Feasibility of full and rapid neuromuscular blockade recovery with sugammadex in myasthenia gravis patients undergoing surgery - a series of 117 cases / $c T. Vymazal, M. Krecmerova, V. Bicek, R. Lischke,
- 520 9_
- $a PURPOSE: Myasthenia gravis (MG) is an autoimmune disease interfering with neuromuscular transmission. Patients are at risk of postoperative residual curarization (PORC) if nondepolarizing muscle relaxants are used. Clinically inapparent insufficient muscle strength may result in hypoventilation and postoperative bronchopneumonia. We describe a cohort of 117 cases in which sugammadex was used in MG patients undergoing surgery with muscle relaxation with rocuronium. METHODS AND PATIENTS: We anesthetized 117 patients with MG using rocuronium and sugammadex as neuromuscular blockade reversal agent. One hundred five patients underwent surgical thymectomy and 12 underwent cholecystectomy (five laparotomic and seven laparoscopic). We measured time from sugammadex administration to recovery and to extubation, using the TOF-Watch(®) (series of four consecutive electrical impulses [the train-of-four] >0.9). We tracked peripheral capillary oxygen saturation (SpO2) <95%, elevation of partial pressure of carbon dioxide (pCO2) >10% above baseline, number of reintubations within the first 48 hours, and number of pneumonias within 120 hours, postoperatively. Results were processed as average, minimum, and maximum values. RESULTS: The period needed to reach train-of-four of 0.9 following sugammadex administration was on average 117 seconds (minimum of 105 seconds/maximum of 127 seconds) and differed within deviation <10%. The time to extubation following sugammadex administration was on average 276 seconds (minimum of 251 seconds/maximum of 305 seconds) and differed minimally among patients as well. We observed no SpO2 <95%, no pCO2 elevation >10% above a baseline, no emergent reintubation within the first 48 hours, and no pneumonia diagnosed on clinical basis within 120 hours, postoperatively in all 117 patients. CONCLUSION: In this cohort of MG patients undergoing surgery using rocuronium and sugammadex, we did not observe any signs of postoperative residual curarization and respiratory depression. The neuromuscular blockade recovery was reliable, predictable, and rapid.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Krecmerova, Martina $u Department of Anaesthesiology and ICM, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Bicek, Vladimír $u Department of Anaesthesiology and ICM, 2nd Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 700 1_
- $a Lischke, Robert $u 3rd Surgical Department of 1st Faculty of Medicine, Charles University in Prague and Motol University Hospital, Prague, Czech Republic.
- 773 0_
- $w MED00165795 $t Therapeutics and clinical risk management $x 1176-6336 $g Roč. 11, č. - (2015), s. 1593-6
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/26508869 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160108 $b ABA008
- 991 __
- $a 20160127122349 $b ABA008
- 999 __
- $a ind $b bmc $g 1103187 $s 925112
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 11 $c - $d 1593-6 $e 20151015 $i 1176-6336 $m Therapeutics and clinical risk management $n Ther. clin. risk manag. $x MED00165795
- LZP __
- $a Pubmed-20160108